Use of the quinazoline derivative ZD6474 combined with gemcitabine and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability

Details for Australian Patent Application No. 2003269253 (hide)

International Classifications

Event Publications

15 January 2004 Complete Application Filed

Priority application(s): 0223380.7 09.10.02 GB

3 June 2004 Application Open to Public Inspection

Published as AU-B-2003269253

5 April 2007 Application Accepted

Published as AU-B-2003269253

2 August 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.